ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 450.2 | 424.7 | 386.1 |
| Other income | 5.1 | 8.2 | 7.5 |
| Total income | 455.3 | 432.8 | 393.6 |
| Profit before exceptional items & tax | 77.7 | 69.7 | 61.2 |
| Exceptional items | 0.0 | -0.1 | 0.0 |
| Profit before tax | 77.7 | 69.8 | 61.2 |
| Net profit | 56.9 | 51.0 | 45.2 |
| Operating margin | 17.1% | 16.1% | 15.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +25.90% |
|---|---|
| Net profit, quarter on quarter | +11.60% |
| Revenue, year on year | +16.60% |
| Operating profit, year on year | +35.20% |
| Operating profit, quarter on quarter | +18.00% |
BSE results filing, NSE: METROPOLIS. Figures extracted from the filing.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹574.70
- Market cap
- ₹11,927 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 53.2×Sector 54.5×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Earnings Call Transcript: Key Takeaways
Metropolis delivered a robust 16% revenue growth, beating prior 12-13% organic guidance. Operating leverage is kicking in, with H1 margins expanding 190 bps despite heavy monsoon headwinds and no price hikes.
- Call
- Guides 16% growth
Metropolis Healthcare Dividend
Metropolis Healthcare declared an interim dividend of ₹1 per equity share for FY 26-27. The record date is 9 November 2026.
Metropolis Healthcare Results Update
Metropolis Healthcare posted Q2 FY27 revenue up 16% to ₹497 crore and PAT up 43% to ₹75 crore. Board declared a ₹1 per share interim dividend.
Metropolis Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 497 Cr (+16% YoY), EBITDA INR 135 Cr at 27.2% margin, PAT INR 75 Cr (+43%). H1 revenue INR 947 Cr (+16%). Strategy is Metropolis 3.0, focused on tech, science and profitable growth.
Metropolis Healthcare Q2 FY27 Results: Net Profit ₹75.5 Cr, Up 42.7% YoY
Metropolis Healthcare Ltd reported revenue from operations of ₹496.8 Cr (+15.8% YoY) and net profit of ₹75.5 Cr (+42.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹75.5 Cr · +42.7% YoY
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare granted 24,060 RSUs and 3,58,920 ESOPs under its 2025 plans, and allotted 65,600 shares under its RSU Plan 2020.